References
- Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012;60:2263-70. https://doi.org/10.1016/j.jacc.2012.04.063
- Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007;115:135-43. https://doi.org/10.1016/j.ijcard.2006.04.026
- Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine. 3rd ed. Oxford: Oxford Univeristy Press; 1999. p. 936.
- Patel P, Dokainish H, Tsai P, Lakkis N. Update on the association of inflammation and atrial fibrillation. J Cardiovasc Electrophysiol 2010;21:1064-70. https://doi.org/10.1111/j.1540-8167.2010.01774.x
- Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007;49:1642-8. https://doi.org/10.1016/j.jacc.2006.12.042
- Kornej J, Reinhardt C, Kosiuk J, et al. Response of high-sensitive C-reactive protein to catheter ablation of atrial fibrillation and its relation with rhythm outcome. PLoS One 2012;7:e44165. https://doi.org/10.1371/journal.pone.0044165
- Uthamalingam S, Patvardhan EA, Subramanian S, et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 2011;107:433-8. https://doi.org/10.1016/j.amjcard.2010.09.039
- Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008;395:27-31. https://doi.org/10.1016/j.cca.2008.04.019
- Shao Q, Chen K, Rha SW, Lim HE, Li G, Liu T. Usefulness of neutrophil/lymphocyte ratio as a predictor of atrial fibrillation: a meta-analysis. Arch Med Res 2015;46:199-206. https://doi.org/10.1016/j.arcmed.2015.03.011
- Canpolat U, Aytemir K, Yorgun H, et al. Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation. Am J Cardiol 2013;112:513-9. https://doi.org/10.1016/j.amjcard.2013.04.015
- Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91. https://doi.org/10.1016/j.amjcard.2009.09.007
- Karavelioglu Y, Karapinar H, Yuksel M, et al. Neutrophil to lymphocyte ratio is predictor of atrial fibrillation recurrence after cardioversion with amiodarone. Clin Appl Thromb Hemost 2015;21:5-9. https://doi.org/10.1177/1076029613518368
- Adamsson Eryd S, Borne Y, Melander O, et al. Red blood cell distribution width is associated with incidence of atrial fibrillation. J Intern Med 2014;275:84-92. https://doi.org/10.1111/joim.12143
- Liu T, Shao Q, Miao S, et al. Red cell distribution width as a novel, inexpensive marker for paroxysmal atrial fibrillation. Int J Cardiol 2014;171:e52-3. https://doi.org/10.1016/j.ijcard.2013.11.112
- Lee KH, Park HW, Cho JG, et al. Red cell distribution width as a novel predictor for clinical outcomes in patients with paroxysmal atrial fibrillation. Europace 2015;17 Suppl 2:ii83-8. https://doi.org/10.1093/europace/euv210
- Roberts LJ 2nd, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-13. https://doi.org/10.1016/S0891-5849(99)00264-6
- Schwedhelm E, Boger RH. Application of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease. Clin Chem Lab Med 2003;41:1552-61.
- Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-47. https://doi.org/10.1093/eurheartj/ehs253
- Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol 2008;52:306-13. https://doi.org/10.1097/FJC.0b013e31817f9398
- Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26:2083-92. https://doi.org/10.1093/eurheartj/ehi350
- Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007;50:2021-8. https://doi.org/10.1016/j.jacc.2007.06.054
- Huang CX, Liu Y, Xia WF, Tang YH, Huang H. Oxidative stress: a possible pathogenesis of atrial fibrillation. Med Hypotheses 2009;72:466-7. https://doi.org/10.1016/j.mehy.2008.08.031
- Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 2003;9:RA225-9.
- Reilly SN, Jayaram R, Nahar K, et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 2011;124:1107-17. https://doi.org/10.1161/CIRCULATIONAHA.111.029223
- Cangemi R, Celestini A, Calvieri C, et al. Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation. Heart 2012;98:1063-6. https://doi.org/10.1136/heartjnl-2012-301952
- Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89:E32-8.
- Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174-80. https://doi.org/10.1161/01.CIR.104.2.174
- Kim YM, Guzik TJ, Zhang YH, et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005;97:629-36. https://doi.org/10.1161/01.RES.0000183735.09871.61
- Il'yasova D, Ivanova A, Morrow JD, Cesari M, Pahor M. Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. Biomarkers 2008;13:41-51. https://doi.org/10.1080/13547500701617708
- Korantzopoulos P, Papaioannides D, Galaris D, Kokkoris S. Does C-reactive protein represent an oxidative stress marker in cardiovascular disease? Int J Clin Pract 2003;57:252.
Cited by
- Five‐Year Change in the Renal Function After Catheter Ablation of Atrial Fibrillation vol.8, pp.17, 2019, https://doi.org/10.1161/jaha.119.013204
- Red blood cell distribution width and atrial fibrillation vol.14, pp.13, 2017, https://doi.org/10.2217/bmm-2020-0041